DIN 02290960 — MABCAMPATH 30 MG
MABCAMPATH is a solution of Alemtuzumab marketed by SANOFI-AVENTIS CANADA INC. The full Alemtuzumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02290960
- Brand name
- MABCAMPATH
- Active ingredient
- Alemtuzumab
- Strength
- 30 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-CD52 monoclonal antibody (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Alemtuzumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02418320 | LEMTRADA | 12 MG | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |